Zhejiang Conba Pharmaceutical's controlling shareholder plans to increase its holdings of the company's shares by 1.999%.
Kangenbei (600572.SH) announced that based on the firm confidence in the company's development prospects, recognition of the long-term investment value of the company, and the need to further enhance control, the controlling shareholder Zhejiang Medicine Group plans to increase its holdings of the company's shares through block trading on the Shanghai Stock Exchange within 3 months after 15 trading days from the date of the announcement. The planned increase in shares is 50.659 million shares, accounting for 1.999% of the company's total current share capital.
Zhejiang Conba Pharmaceutical (600572.SH) announced that based on its firm confidence in the company's development prospects, recognition of the long-term investment value of the company, and the need to further enhance its control, the company's controlling shareholder Zhejiang Medicine Group plans to increase its holdings of the company's shares through block trading on the Shanghai Stock Exchange within 3 months after 15 trading days from the date of the announcement. The planned increase in shares is 50.65 million shares, accounting for 1.999% of the company's current total share capital.
The second largest shareholder of the company, Zhejiang Conba Pharmaceutical Group Co., Ltd. ("Zhejiang Conba Pharmaceutical Group"), is the block trading transferor in this transaction for Zhejiang Medicine Group's increased shareholding.
Related Articles
QUNABOX GROUP (00917) spent 2.4813 million Hong Kong dollars to repurchase 100,000 shares on December 22nd.
YIDA CHINA (03639): is currently seeking legal advice and actively negotiating repayment arrangements for the outstanding principal amount and accumulated interest of the loan repayment.
QPL INT'L (00243) released its interim results, with a net profit attributable to shareholders of HK$77.895 million, a year-on-year increase of 591.79%.
QUNABOX GROUP (00917) spent 2.4813 million Hong Kong dollars to repurchase 100,000 shares on December 22nd.
YIDA CHINA (03639): is currently seeking legal advice and actively negotiating repayment arrangements for the outstanding principal amount and accumulated interest of the loan repayment.
QPL INT'L (00243) released its interim results, with a net profit attributable to shareholders of HK$77.895 million, a year-on-year increase of 591.79%.
